Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 371-380 of 640 total displayed.

Past content (since Jan 1999):

Scientific Contributions
Raloxifene Prevents Cardiac Hypertrophy and Dysfunction in Pressure-Overloaded Mice
Hisakazu Ogita, Koichi Node, Yulin Liao, Fuminobu Ishikura, Shintaro Beppu, Hiroshi Asanuma, Shoji Sanada, Seiji Takashima, Tetsuo Minamino, Masatsugu Hori, and Masafumi Kitakaze
Hypertension 2004;43:237-242; published online before print as doi:10.1161/01.HYP.0000109320.25921.b1 [Abstract] [Full text]  

Corcoran Lecture
Peroxisome Proliferator-Activated Receptor {gamma}: Implications for Cardiovascular Disease
Willa A. Hsueh and Dennis Bruemmer
Hypertension 2004;43:297-305; published online before print as doi:10.1161/01.HYP.0000113626.76571.5b [Abstract] [Full text]  

Scientific Contributions
Mediators of Bradykinin-Induced Vasorelaxation in Human Coronary Microarteries
Wendy W. Batenburg, Ingrid M. Garrelds, Jorge P. van Kats, Pramod R. Saxena, and A. H. Jan Danser
Hypertension 2004;43:488-492; published online before print as doi:10.1161/01.HYP.0000110904.95771.26 [Abstract] [Full text]  

Scientific Contributions
Sympathetic Responses to Stress and Rilmenidine in 2K1C Rabbits. Evidence of Enhanced Nonvascular Effector Mechanism
Geoffrey A. Head and Sandra L. Burke
Hypertension published January 26, 2004, doi:10.1161/01.HYP.0000116301.02975.aa [Abstract]  

Hypertension Grand Rounds
Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone. Theory and Therapy
Theodore L. Goodfriend and David A. Calhoun
Hypertension published January 19, 2004, doi:10.1161/01.HYP.0000116223.97436.e5 [Abstract]  

Corcoran Lecture
Peroxisome Proliferator-Activated Receptor {gamma}: Implications for Cardiovascular Disease
Willa A. Hsueh and Dennis Bruemmer
Hypertension published January 19, 2004, doi:10.1161/01.HYP.0000113626.76571.5b [Abstract]  

Scientific Contributions
Hypersensitivity of the Adrenal Cortex to Trophic and Secretory Effects of Angiotensin II in Lyon Genetically-Hypertensive Rats
Frédérick Aguilar, Ming Lo, Bruno Claustrat, José Maria Saez, Jean Sassard, and Jacques Yuan Li
Hypertension 2004;43:87-93; published online before print as doi:10.1161/01.HYP.0000107194.44040.d4 [Abstract] [Full text]  

Scientific Contributions
Mediators of Bradykinin-Induced Vasorelaxation in Human Coronary Microarteries
Wendy W. Batenburg, Ingrid M. Garrelds, Jorge P. van Kats, Pramod R. Saxena, and A. H. Jan Danser
Hypertension published December 22, 2003, doi:10.1161/01.HYP.0000110904.95771.26 [Abstract]  

Scientific Contributions
Raloxifene Prevents Cardiac Hypertrophy and Dysfunction in Pressure-Overloaded Mice
Hisakazu Ogita, Koichi Node, Yulin Liao, Fuminobu Ishikura, Shintaro Beppu, Hiroshi Asanuma, Shoji Sanada, Seiji Takashima, Tetsuo Minamino, Masatsugu Hori, and Masafumi Kitakaze
Hypertension published December 15, 2003, doi:10.1161/01.HYP.0000109320.25921.b1 [Abstract]  

Scientific Contributions
Hypersensitivity of the Adrenal Cortex to Trophic and Secretory Effects of Angiotensin II in Lyon Genetically-Hypertensive Rats
Frédérick Aguilar, Ming Lo, Bruno Claustrat, José Maria Saez, Jean Sassard, and Jacques Yuan Li
Hypertension published December 1, 2003, doi:10.1161/01.HYP.0000107194.44040.d4 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment